产品详情
靶点信息
JAK2 | ||||
<5 μM |
In vitro | DMSO | 89 mg/mL (191.58 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 24 mg/mL (51.66 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.53 mL | 107.63 mL | 215.26 mL |
0.5 mM | 4.31 mL | 21.53 mL | 43.05 mL |
1 mM | 2.15 mL | 10.76 mL | 21.53 mL |
5 mM | 0.43 mL | 2.15 mL | 4.31 mL |
*The above data is based on the productmolecular weight 464.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A15911 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 464.55 |
Formula | C28H32O6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1226895-15-3 |
Synonyms | FLLL-32, FLLL 32 |
SMILES | O=C(C1(C(/C=C/C2=CC=C(OC)C(OC)=C2)=O)CCCCC1)/C=C/C3=CC=C(OC)C(OC)=C3 |
产品标签
Product Questions
Product Questions
Cyt387 (Momelotinib)
Cyt387 (Momelotinib)是Janus激酶JAK1和JAK2的抑制剂,可作为ATP竞争者,IC50值分别为11和18 nM。
Pexidartinib (PLX3397)
Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。
BMS-911543
BMS-911543是一种有效的、选择性JAK2小分子抑制剂。
R406 besylate
R406 besylate是一种口服酪氨酸激酶抑制剂,IC50为41 nM。对Syk抑制作用强,但是不抑制Lyn,对Flt3的作用比对Syk…
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。